Total Payments
$3,536
2024 Payments
$245.64
Companies
32
Transactions
175
Medicare Patients
1,054
Medicare Billing
$53,927
Payment Breakdown by Category
Food & Beverage$3,505 (99.1%)
Education$31.20 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,505 | 173 | 99.1% |
| Education | $31.20 | 2 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,053 | 47 | $0 (2024) |
| Astellas Pharma US Inc | $394.65 | 21 | $0 (2024) |
| Amgen Inc. | $366.14 | 19 | $0 (2023) |
| PFIZER INC. | $306.52 | 17 | $0 (2024) |
| Hologic, LLC | $292.73 | 11 | $0 (2022) |
| TherapeuticsMD, Inc. | $167.96 | 7 | $0 (2021) |
| Medical Device Business Services, Inc. | $121.15 | 1 | $0 (2017) |
| Novo Nordisk Inc | $86.86 | 6 | $0 (2021) |
| MAYNE PHARMA INC. | $79.67 | 4 | $0 (2022) |
| Exeltis, USA Inc. | $75.60 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $245.64 | 14 | Astellas Pharma US Inc ($102.69) |
| 2023 | $193.41 | 11 | MAYNE PHARMA COMMERCIAL LLC ($56.81) |
| 2022 | $336.14 | 20 | ABBVIE INC. ($139.79) |
| 2021 | $434.76 | 26 | AbbVie Inc. ($266.72) |
| 2020 | $405.49 | 17 | Amgen Inc. ($136.13) |
| 2019 | $986.99 | 35 | AbbVie, Inc. ($397.14) |
| 2018 | $340.77 | 23 | Amgen Inc. ($79.44) |
| 2017 | $592.73 | 29 | PFIZER INC. ($203.51) |
All Payment Transactions
175 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: WOMENS HEALTH | ||||||
| 10/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Biological | ||||||
| 10/10/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: CONTRACEPTIVE | ||||||
| 09/05/2024 | PFIZER INC. | COMIRNATY (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: VACCINES | ||||||
| 08/01/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: Biological | ||||||
| 07/01/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 05/13/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 05/09/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: CONTRACEPTIVE | ||||||
| 04/28/2024 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: WOMENS HEALTH | ||||||
| 04/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Biological | ||||||
| 04/04/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Obesity | ||||||
| 03/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Biological | ||||||
| 02/15/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Obesity | ||||||
| 01/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Biological | ||||||
| 10/19/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Biological | ||||||
| 09/28/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Biological | ||||||
| 09/11/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: HORMONE THERAPY | ||||||
| 08/25/2023 | AbbVie Inc. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: WOMENS HEALTH | ||||||
| 08/10/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Endocrinology | ||||||
| 07/17/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $38.28 | General |
| 06/27/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $18.53 | General |
| 06/08/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Endocrinology | ||||||
| 03/02/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Bone Health | ||||||
| 01/24/2023 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: WOMENS HEALTH | ||||||
| 01/09/2023 | PFIZER INC. | PREMARIN (Drug), MYFEMBREE, PAXLOVID | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 387 | 403 | $35,935 | $22,241 |
| 2022 | 6 | 180 | 198 | $13,814 | $8,530 |
| 2021 | 7 | 263 | 293 | $19,363 | $11,987 |
| 2020 | 6 | 224 | 249 | $18,857 | $11,168 |
Total Patients
1,054
Total Services
1,143
Medicare Billing
$53,927
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77067 | Screening mammography | Office | 2023 | 67 | 67 | $11,725 | $7,598 | 64.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 90 | 90 | $4,230 | $3,207 | 75.8% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 67 | 67 | $4,824 | $3,189 | 66.1% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 79 | 79 | $3,634 | $3,083 | 84.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 30 | $4,328 | $2,542 | 58.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 32 | $3,746 | $1,882 | 50.2% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 20 | 20 | $3,340 | $679.40 | 20.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 16 | 18 | $108.00 | $61.38 | 56.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 37 | $5,106 | $3,049 | 59.7% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 57 | 57 | $2,679 | $2,127 | 79.4% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 43 | 43 | $1,978 | $1,737 | 87.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 22 | $2,046 | $1,141 | 55.8% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 11 | 11 | $1,837 | $381.10 | 20.7% |
| 81002 | Urinalysis, manual test | Office | 2022 | 25 | 28 | $168.00 | $96.24 | 57.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 88 | 88 | $4,136 | $3,314 | 80.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 30 | 37 | $5,106 | $3,044 | 59.6% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 60 | 60 | $2,760 | $2,465 | 89.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 29 | 32 | $2,976 | $2,231 | 75.0% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Office | 2021 | 19 | 19 | $3,173 | $606.56 | 19.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 14 | 30 | $1,050 | $235.37 | 22.4% |
| 81002 | Urinalysis, manual test | Office | 2021 | 23 | 27 | $162.00 | $90.48 | 55.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 39 | 57 | $7,866 | $4,178 | 53.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 77 | 77 | $3,619 | $2,924 | 80.8% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 56 | 56 | $2,576 | $2,269 | 88.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 24 | 27 | $2,511 | $1,253 | 49.9% |
About Dr. Philip Dozier, MD
Dr. Philip Dozier, MD is a Obstetrics & Gynecology healthcare provider based in Dothan, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518925197.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Philip Dozier, MD has received a total of $3,536 in payments from pharmaceutical and medical device companies, with $245.64 received in 2024. These payments were reported across 175 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($3,505).
As a Medicare-enrolled provider, Dozier has provided services to 1,054 Medicare beneficiaries, totaling 1,143 services with total Medicare billing of $53,927. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location Dothan, AL
- Active Since 05/03/2006
- Last Updated 03/11/2010
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1518925197
Products in Payments
- Orilissa (Drug) $437.87
- Prolia (Biological) $261.17
- LO LOESTRIN FE (Drug) $253.15
- MYRBETRIQ (Drug) $198.17
- PREMARIN ORALS (Drug) $196.44
- ORIAHNN (Drug) $165.97
- Myosure (Device) $134.45
- Veozah (Drug) $134.43
- ENSEAL Product Family (Device) $121.15
- LILETTA (Drug) $95.03
- BIJUVA (Drug) $93.75
- SLYND (Drug) $75.60
- PREMARIN (Drug) $74.72
- Saxenda (Drug) $70.79
- Omniscope (Device) $69.94
- ORILISSA (Drug) $64.14
- Myrbetriq (Drug) $62.05
- IMVEXXY (Drug) $61.29
- Bonjesta (Drug) $57.57
- EVENITY (Biological) $49.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Dothan
Praful Patel, M.d, M.D
Obstetrics & Gynecology — Payments: $51,448
Obstetrics & Gynecology $51,448
John Gordon, D.o, D.O
Obstetrics & Gynecology — Payments: $4,523
Obstetrics & Gynecology $4,523
Dr. Scott Gilchrist, Md, MD
Obstetrics & Gynecology — Payments: $4,054
Obstetrics & Gynecology $4,054
Bryan Mullins, Md, MD
Obstetrics & Gynecology — Payments: $3,803
Obstetrics & Gynecology $3,803
Christopher Nicholls, Md, MD
Obstetrics & Gynecology — Payments: $3,660
Obstetrics & Gynecology $3,660
Dr. Stephanie Gibson, Md, MD
Obstetrics & Gynecology — Payments: $3,394
Obstetrics & Gynecology $3,394